PDEX
Price
$60.24
Change
+$2.59 (+4.49%)
Updated
Nov 3 closing price
Capitalization
192.97M
92 days until earnings call
Intraday BUY SELL Signals
WAT
Price
$459.90
Change
+$10.37 (+2.31%)
Updated
Nov 3 closing price
Capitalization
44.17B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PDEX vs WAT

PDEX vs WAT Comparison Chart in %
View a ticker or compare two or three
VS
PDEX vs. WAT commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDEX is a Buy and WAT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PDEX with price predictions
Nov 03, 2026

PDEX in +4.17% Uptrend, growing for three consecutive days on October 28, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PDEX advanced for three days, in 242 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PDEX's RSI Oscillator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on PDEX as a result. In 81 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

PDEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PDEX turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 42 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

PDEX moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PDEX crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PDEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for PDEX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. PDEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.051) is normal, around the industry mean (4.946). P/E Ratio (14.208) is within average values for comparable stocks, (38.797). Projected Growth (PEG Ratio) (0.400) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.061) is also within normal values, averaging (56.876).

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

A.I.Advisor
a Summary for WAT with price predictions
Nov 03, 2026

WAT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for WAT turned positive on October 21, 2026. Looking at past instances where WAT's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on WAT as a result. In 59 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

Following a +2.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where WAT advanced for three days, in 179 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 118 of 207 cases where WAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Bearish Trend Analysis

The 10-day RSI Indicator for WAT moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 15 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 44%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 70 cases where WAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

WAT broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. WAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.907) is normal, around the industry mean (65.986). WAT has a moderately high P/E Ratio (112.947) as compared to the industry average of (3.066). Projected Growth (PEG Ratio) (1.649) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (6.752) is also within normal values, averaging (9.775).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
PDEX vs WAT: Fundamental Ratings
PDEX
WAT
OUTLOOK RATING
1..100
1822
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
5451
SMR RATING
1..100
3189
PRICE GROWTH RATING
1..100
5619
P/E GROWTH RATING
1..100
143
SEASONALITY SCORE
1..100
6575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDEX's Valuation (57) in the Medical Or Nursing Services industry is in the same range as WAT (88) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (51) in the Medical Specialties industry is in the same range as PDEX (54) in the Medical Or Nursing Services industry. This means that WAT’s stock grew similarly to PDEX’s over the last 12 months.

PDEX's SMR Rating (31) in the Medical Or Nursing Services industry is somewhat better than the same rating for WAT (89) in the Medical Specialties industry. This means that PDEX’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's Price Growth Rating (19) in the Medical Specialties industry is somewhat better than the same rating for PDEX (56) in the Medical Or Nursing Services industry. This means that WAT’s stock grew somewhat faster than PDEX’s over the last 12 months.

WAT's P/E Growth Rating (3) in the Medical Specialties industry is in the same range as PDEX (14) in the Medical Or Nursing Services industry. This means that WAT’s stock grew similarly to PDEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDEXWAT
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
44%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
64%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 7 days ago
64%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
58%
Bullish Trend 1 day ago
57%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (PDEX: $60.24 vs. WAT: $459.90)
Brand notoriety: PDEX and WAT are both not notable
PDEX represents the Pharmaceuticals: Other, while WAT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PDEX: 119% vs. WAT: 211%
Market capitalization -- PDEX: $192.97M vs. WAT: $45.18B
PDEX [@Pharmaceuticals: Other] is valued at $192.97M. WAT’s [@Medical Specialties] market capitalization is $45.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $155.71B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.49B. The average market capitalization across the [@Medical Specialties] industry is $21.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDEX’s FA Score shows that 2 FA rating(s) are green while WAT’s FA Score has 2 green FA rating(s).

  • PDEX’s FA Score: 2 green, 3 red.
  • WAT’s FA Score: 2 green, 3 red.
According to our system of comparison, PDEX is a better buy in the long-term than WAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDEX’s TA Score shows that 5 TA indicator(s) are bullish while WAT’s TA Score has 4 bullish TA indicator(s).

  • PDEX’s TA Score: 5 bullish, 5 bearish.
  • WAT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than PDEX.

Price Growth

PDEX (@Pharmaceuticals: Other) experienced а -3.26% price change this week, while WAT (@Medical Specialties) price change was -1.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.70%. For the same industry, the average monthly price growth was -1.70%, and the average quarterly price growth was +10.08%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.30%. For the same industry, the average monthly price growth was -5.24%, and the average quarterly price growth was +42.12%.

Reported Earning Dates

PDEX is expected to report earnings on Feb 04, 2027.

WAT is expected to report earnings on Feb 17, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (-0.70% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-2.30% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and TCMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and TCMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
+4.49%
TCMD - PDEX
24%
Poorly correlated
+8.35%
PRE - PDEX
23%
Poorly correlated
-1.70%
KRMD - PDEX
23%
Poorly correlated
+1.64%
WAT - PDEX
23%
Poorly correlated
+2.31%
GKOS - PDEX
23%
Poorly correlated
-2.33%
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been loosely correlated with A. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
+2.31%
A - WAT
65%
Loosely correlated
+2.02%
RVTY - WAT
60%
Loosely correlated
+7.84%
BRKR - WAT
58%
Loosely correlated
+1.45%
TMO - WAT
58%
Loosely correlated
+2.30%
CRL - WAT
57%
Loosely correlated
+3.94%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ROKT103.240.77
+0.75%
State Street SPDR S&P Kensho Final Frontiers ETF (ROKT)
SAWS22.28N/A
N/A
AAM Sawgrass US Small Cap Quality Growth ETF (SAWS)
XMVM74.47-0.47
-0.63%
Invesco S&P MidCap Value with Momentum ETF (XMVM)
KTEC10.90-0.10
-0.91%
KraneShares Hang Seng TECH Index ETF (KTEC)
SIL71.27-1.05
-1.45%
Global X Silver Miners ETF (SIL)